Paolo Tarantino
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Paolo Tarantino
Apr 20, 2024, 20:17 |
Insight
Paolo Tarantino: Tumor-infiltrating lymphocytes (TILs): not only prognostic in Triple-Negative Breast Cancer
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Tumor-infiltrating lymphocytes (TILs): not…
Apr 17, 2024, 17:38 |
Insight
Paolo Tarantino: Exciting session at MLS Cleveland Clinic Congress
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Exciting session at…
Apr 16, 2024, 11:06 |
Blog
Paolo Tarantino: Outstanding presentation on MRD/ctDNA by Heather Parsons at the 3rd Transatlantic Exchange in Oncology
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Outstanding presentation on…
Apr 16, 2024, 00:17 |
Blog
Paolo Tarantino: We review best practices and future perspectives for the identification of patients with HER2-low Breast Cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn: "In our latest…
Apr 15, 2024, 11:31 |
Blog
Shilpa Gupta: Excited to co-host with at Chandler Park an amazing all-star faculty for Precision Oncology summit in Cleveland on April 13
Shilpa Gupta, Director, Genitourinary Oncology, Cleveland Clinic shareda post by The Medical Educator Consortium on X,…
Apr 14, 2024, 13:47 |
Insight
Paolo Tarantino: Do patients with these small triple-negative tumors benefit from chemotherapy?
Paolo Tarantino, Research Fellow presso Dana-Farber Cancer Institute, shared a post on LinkedIn: "One third of…
Apr 11, 2024, 12:21 |
Blog
Paolo Tarantino: Easier to get a ticket for a Taylor Swift concert than to find a seat at the AACR24 Next Generation ADC session!
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 10, 2024, 05:00 |
Blog
Paolo Tarantino: Our study on the prognosis of small TNBCs is out in NPJ Journals
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Our study…
Apr 8, 2024, 15:49 |
Insight
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X: "The TRAIN3…
Apr 8, 2024, 15:17 |
Blog
Petros Grivas: Can’t wait to join Paolo Tarantino and Helena Yu to review ADCs across solid tumors
Petros Grivas, Associate Professor at the University of Washington, recently shared a post by Paolo…
2
3
4
5
6
All:
115
Posts:
31 - 40
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube